Table 2 Comparison between the ARID1A immunoreactivity and PIK3CA mutations in ovarian clear-cell carcinomas

From: Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations

PIK3CA mutations

Number of cases (%)

P-value

 

ARID1A

ARID1A

 

In exon 9 or 20

Deficient

Intact

 

Present (n=17)

12 (71)

5 (29)

0.083

Absent (n=25)

11 (44)

14 (56)

 
Back to article page